lilly weight loss drug news - Search News

Zepbound, Sleep Apnea and Food and Drug Administration

Hosted on MSN · 4d

Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea

Key Takeaways Eli Lilly's Zepbound has been approved by the Food and Drug Administration (FDA) as a treatment for adults with sleep apnea and obesity, the drugmaker said after the bell Friday.Trials of the Lilly drug found that it helped reduce the number of breathing disruptions in an average night of sleep.

Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea

The U.S. Food and Drug Administration on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug greenlighted to directly treat patients with the common sleeping disorder.

INSIDER on MSN · 3d

The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.

Tirzepatide, the active ingredient in Zepbound and Mounjaro, is no longer in short supply, the FDA says.Cheaper versions of the drug, known as compounded tirzepatide, might be restricted in 2025.Patients could face higher costs and tougher access,

Des Moines Register3d

Off-brand versions of Lilly weight loss drug must be pulled off market, could mean higher prices

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been ...

Bloomberg L.P. on MSN8d

Lilly’s US Weight-Loss Drug Shortage Ends, Curtailing Copies

Eli Lilly & Co.’s diabetes and weight-loss drugs Mounjaro and Zepbound are no longer in short supply in the US, which ...

3d

Retail investors buy Novo dip after disappointing weight-loss drug data

U.S. retail investor fund flows into Novo Nordisk surged 32-fold on Friday, as the Danish drugmaker's weaker-than-expected ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results